Updated analysis is from the Phase III IMbrave150 study
MHRA submission is based on same application filed with the EMA
Investigational antibody targets a modified form of beta amyloid called N3pG
First patient in global trial dosed in the UK
Nearly a third (31.2%) of all deaths in England and Wales in the week ending 1 January involved […]
Andrew Pollard was in a French taxi when he realised what was coming.On his way to a meeting […]
The publication of the first recommendations from the independent review of maternity services at Shrewsbury and Telford NHS […]
Cases of covid-19 are surging and doctors warn of the NHS being overwhelmed. On 2 January 2021, there […]
Study will evaluate the role of smart devices on monitoring cognitive health
CCS1477 has a novel mechanism of action compared to existing treatments